Agricultural Glyphosate Spray Detected in Pregnant People Living Near Fields
By Lori Solomon HealthDay Reporter
TUESDAY, Dec. 12, 2023 -- Pregnant people living near agriculture fields have significantly increased urinary glyphosate concentrations during the spray season, according to a study published online Dec. 6 in Environmental Health Perspectives.
Cynthia L. Curl, Ph.D., from Boise State University in Idaho, and colleagues evaluated glyphosate exposure during pregnancy in relation to residential proximity to agriculture as well as agricultural spray season. The analysis included 453 urine samples collected biweekly from a cohort of 40 pregnant people in Southern Idaho (February through December 2021).
The researchers found that among participants living near fields (<0.5 km), urinary glyphosate was detected more frequently and at significantly increased geometric mean (GM) concentrations during the spray season versus the nonspray season (81 versus 55 percent; 0.228 versus 0.150 µg/L). For participants who lived far from fields, neither glyphosate detection, frequency, nor GMs differed in the spray versus nonspray season (66 versus 64 percent; 0.154 versus 0.165 µg/L).
"Because of the relatively large number of samples per participant, we were able to assess exposures during both spray and nonspray seasons using longer-term averages that reduced intra-individual variability," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted December 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.